Psoriatic Arthritis

PHILADELPHIA — Interleukin-17 inhibition with bimekizumab yields strong joint and skin effects up to week 52 in patients with active psoriatic arthritis, according to data presented at ACR Convergence 2022.

PHILADELPHIA — In patients with psoriatic arthritis, upadacitinib showed greater improvement compared with both placebo and adalimumab as assessed by the Routine Assessment of Patient Index Data 3, or RAPID3, scores.

PHILADELPHIA — Patients who switched from one infliximab biosimilar to another experienced comparable treatment retention rates, according to data presented at ACR Convergence 2022.

In patients with autoimmune rheumatic diseases, vaccination against COVID-19 does not appear to correlate with increased flares, regardless of disease status, previous exposure and vaccine type, according to data published in Rheumatology.

Healio has launched a new point-of-care tool with modules on medical conditions to help clinicians treat patients using reliable information.

SAN DIEGO — Domain-based or treat-to-target approaches can be effective in managing patients with complex psoriatic arthritis and avoiding “just trial and error,” according to a speaker at the Congress of Clinical Rheumatology West.

Inflammatory bowel disease was found to have a positive association with both psoriasis and psoriatic arthritis, suggesting it is a causal risk factor for these two chronic diseases, according to a study.

Among patients with similar psoriatic arthritis disease activity and therapy, women demonstrate higher levels of disease burden than men, according to data published in The Journal of Rheumatology.

The Congress of Clinical Rheumatology-West will be held in a different venue in San Diego this year, but that should have no impact on the quality of the program.

Online forums, chatrooms and communities are often able help patients with chronic illness find comfort by connecting with other patients sharing their disease burden.